top of page

QuanMol Tech.

Founded Year:

2022

Stage:

Seed+

Website:

Committed to transforming the drug development domain, QuanMol's platform equips chemists with the tools to detect less-than-ideal substrates, offering them pragmatic solutions grounded in robust reasoning. Mimicking the process of engaging with experienced peers, QuanMol seamlessly connects theoretical chemistry with real-world application. Harnessing tools such as the Thinker module, the company promotes intuitive interfaces while integrating advanced multi-modeling interaction analytics, solidifying its leadership in drug refinement and molecular studies.

Subscribe to our news letter. Don't miss out!

Thanks for subscribing!

©2022 H7 BioCapital

All rights reserved.

bottom of page